HDE supplement

H020007 S049: SOLETRA/LEADS/EXTENSIONS/ACTIVA THERAPY DYSTONIA KIT

FDA HDE supplement · 30-day notice · MEDTRONIC NEUROMODULATION

Key facts

Original HDE H020007
Supplement number S049
Supplement type 30-day notice
Reason for the supplement process change - manufacturer/sterilizer/packager/supplier
Trade name SOLETRA/LEADS/EXTENSIONS/ACTIVA THERAPY DYSTONIA KIT
Generic name Implanted subcortical electrical stimulator (motor disorders)
Applicant MEDTRONIC NEUROMODULATION
Product code MRU
Received date Jun 29, 2011
Decision date Jul 29, 2011

At a glance

  • No Approval order on file

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About HDE supplements

An HDE supplement asks FDA to approve a change to a Humanitarian Use Device that already holds a humanitarian device exemption.

Source: U.S. Food and Drug Administration (FDA), Humanitarian Device Exemption (HDE) database · Source date:

Browse all HDE supplements